This is particularly significant for future studies as the identity of the dysfunctional regulators in CLL BCR signaling (possibly a differentially-regulated phosphatase) must carry more specificity towards pPLCγ2 inhibition compared to other kinases. Here, BCR is linked to B-cell chronic lymphocytic leukemia.